First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
25 hedge funds and large institutions have $12.9M invested in First Trust Nasdaq Pharmaceuticals ETF in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$568K | |
| 2 | +$381K | |
| 3 | +$216K | |
| 4 |
PPWM
Paragon Private Wealth Management
Lexington,
Kentucky
|
+$118K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$65.5K |
Top Sellers
| 1 | -$1.77M | |
| 2 | -$1.2M | |
| 3 | -$1.13M | |
| 4 |
GSIAS
Garden State Investment Advisory Services
Red Bank,
New Jersey
|
-$565K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$352K |